Science News
from research organizations

Toxic Ebola protein fragment identified

Date:
January 21, 2015
Source:
Louisiana State University Health Sciences Center
Summary:
A fragment of an Ebola virus protein that is toxic to cells and may contribute to infection and illness, has been identified by researchers. The 2014 Ebola epidemic is the largest in history, affecting multiple countries in West Africa. Two imported cases, including one death, and two locally acquired cases in healthcare workers have been reported in the United States. As of January 16, 2015, the CDC and World Health Organization report 13,510 laboratory-confirmed cases and 8,483 deaths worldwide.
Share:
FULL STORY

William Gallaher, PhD, Emeritus Professor of Microbiology, Immunology & Parasitology at LSU Health New Orleans School of Medicine, has discovered a fragment of an Ebola virus protein that is toxic to cells and may contribute to infection and illness. The findings were published online January 20, 2015, in the open access journal, Viruses.

The fragment was found within a grouping of amino acids that is made in parallel with the protein involved in attachment of the virus to cells. Called the "Delta peptide," it has been shown recently to block the Ebola virus from attaching to already-infected cells. The new findings suggest that Delta peptide possibly functions by changing membrane permeability.

Following his discovery, Dr. Gallaher contacted Robert Garry, PhD, Professor of Microbiology and Immunology at Tulane University School of Medicine, a longtime collaborator, to produce a structural model and potential mechanism of action. The results of that modeling work were fashioned into a manuscript that was subjected to rigorous peer view by experts in the field and are being made public only after acceptance into a special issue on "Advances in Ebolavirus, Marburgvirus, and Cuevavirus Research 2014-2015" in Viruses.

Although preliminary studies using synthetic peptides have confirmed the potential of the fragment, its specific role and potency in its natural environment within Ebola virus-infected cells are yet to be determined. However, Dr. Gallaher and his colleagues have determined how to deactivate the toxic properties of the Ebola protein fragment in the laboratory environment. He and his colleagues are also developing inhibitors of the toxic mechanism, which may ultimately be useful as drugs, should a role for Delta peptide in Ebola virus disease become established by future studies.

According to the Centers for Disease Control and Prevention (CDC), the 2014 Ebola epidemic is the largest in history, affecting multiple countries in West Africa. Two imported cases, including one death, and two locally acquired cases in healthcare workers have been reported in the United States. As of January 16, 2015, the CDC and World Health Organization report 13,510 laboratory-confirmed cases and 8,483 deaths worldwide.


Story Source:

Materials provided by Louisiana State University Health Sciences Center. Note: Content may be edited for style and length.


Journal Reference:

  1. lliam Gallaher, Robert Garry. Modeling of the Ebola Virus Delta Peptide Reveals a Potential Lytic Sequence Motif. Viruses, 2015; 7 (1): 285 DOI: 10.3390/v7010285

Cite This Page:

Louisiana State University Health Sciences Center. "Toxic Ebola protein fragment identified." ScienceDaily. ScienceDaily, 21 January 2015. <www.sciencedaily.com/releases/2015/01/150121103304.htm>.
Louisiana State University Health Sciences Center. (2015, January 21). Toxic Ebola protein fragment identified. ScienceDaily. Retrieved May 8, 2017 from www.sciencedaily.com/releases/2015/01/150121103304.htm
Louisiana State University Health Sciences Center. "Toxic Ebola protein fragment identified." ScienceDaily. www.sciencedaily.com/releases/2015/01/150121103304.htm (accessed May 8, 2017).